Associates of Cape Cod

Overview

Associates of Cape Cod, founded in 1974 and headquartered in the United States, operates within the business services sector, specifically focusing on research and development, manufacturing, and healthcare. The company specializes in the production of medical devices and chemicals, with a strong emphasis on life sciences manufacturing, including biotech and pharmaceuticals. A notable aspect of their expertise is in endotoxin testing, as evidenced by their publication of the "APR_EndotoxinSupplement_2025_rCR_Implementation_Guide." This document serves as a compliance guide for the implementation of their PyroSmart NextGen® (PSNG) recombinant cascade reagent, aimed at quality control professionals in various sectors. The guide outlines the necessary steps for integrating this reagent into quality control systems, emphasizing the importance of secure supply chains and sustainability. Additionally, it provides educational content on best practices for reagent handling, risk assessment, and regulatory considerations. Associates of Cape Cod employs between 51 to 200 individuals and has reported revenue of approximately $25.6 million.

Industry